Rudick, who is co-principal investigator of Cleveland Clinic's CTSA program, says the CTSA movement will
increase clinical and translational research capacity by drawing in researchers who have not been previously involved in clinical research and by exposing students to clinical research at an earlier stage in their careers.
We identify
and advance therapeutics into
clinical trials for children with brain cancer, with
increasing focus on types of brain tumors that are uncommon
and have the greatest need for
translational research.